FirstAlerts

Medline Recalls Integrated Arterial Catheters in Class I Action Over Excess Material on Catheter Hub

The FDA says excess material left by a manufacturing issue could detach into the bloodstream; no injuries or deaths have been reported, and the recall remains open.

By AI ReporterFirst reported Feb 6, 2025, 12:00 a.m. ETWritten Aug 7, 2026, 8:55 p.m. ET

More on this incident

is removing Integrated Arterial Catheters supplied inside arterial line insertion kits, bundles, trays and insertion trays, in an action the U.S. Food and Drug Administration has classified as . The FDA's enforcement record, recall number , gives an initiation date of 31 December 2024. is the FDA's most serious category, used where there is a reasonable probability that using the product will cause serious harm or death, according to the agency's own [recall definitions](https://www.fda.gov/safety/industry-guidance-recalls/recalls-background-and-definitions). The action is still developing. According to the FDA notice, a manufacturing issue caused excess material to be present on the catheter hub, and that material could detach, potentially entering the body at the insertion place or the bloodstream. The agency states the hazard as serious adverse health consequences including blockage of blood vessels (embolism) and death. The FDA notice says there have been no reported injuries and no reports of death. The FDA tells users not to use Integrated Arterial Catheters from the affected item numbers and lots, to check stock immediately, to quarantine all affected product, to remove the affected component before using the kit, and to complete the response form at https://recalls.medline.com using Recall Reference #: . The affected item numbers listed are ART1185B/10653160379225, ART255/10653160367598, ART350/10653160362050, ART355/10653160361817, ART475/10653160367659, ART535A/10653160367604, ART545A/10653160375135, ART775C/10653160366102, ART840/10653160366966, ART890B/10653160360834, ART600/10653160312727 and ART690/10653160318019. Lots listed are: ART1185B — 2024102590; ART255 — 2024082690, 2024101590; ART350 — 2024093090; ART355 — 2024081290, 2024112590; ART475 — 2024100790, 2024073090, 2024081590, 2024090990; ART535A — 2024100890, 2024080190; ART545A — 2024102890; ART600 — 2024101090; ART690 — 2024092490; ART775C — 2024083090; ART840 — 2024082390, 2024093090; ART890B — 2024100990. The FDA describes the product as an arterial catheter used to continuously monitor blood pressure and take blood samples from patients. Background reference material from the National Library of Medicine describes an arterial catheter as a thin, flexible plastic tube, typically single-lumen and a few centimetres long, made of a fluoropolymer such as PTFE or of polyurethane in gauges around 18–24, inserted through the skin into a peripheral artery — most often the radial artery at the wrist, sometimes the femoral or brachial artery — and connected to pressure tubing and a transducer. An "integrated" catheter is built as a single coaxial assembly combining the introducer needle and guidewire in one unit, supplied as one component inside a pre-packaged sterile kit or tray. These are not consumer products: they are single-use devices supplied to hospitals and clinics and placed by trained clinicians in intensive care units, operating rooms and emergency departments, so those affected are hospitals, procurement departments, clinical staff and the patients the kits are used on. The FDA's enforcement database records no other enforcement action by this firm. That history says nothing about fault in this action.

Was this report accurate and useful?

Sources

Revision history

  1. Version 18 Aug 2026, 01:09current

    First published.

  2. Version 18 Aug 2026, 00:55current

    First published.

  3. Version 18 Aug 2026, 00:59current

    First published.

  4. Version 18 Aug 2026, 01:05current

    First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.